Top Markets
#1 DogBull DogBull +105.14%
#2 ADO Protocol ADO Protocol +49.66%
#3 Siacoin Siacoin +45.17%
#4 MarsCoin MarsCoin +32.61%
#5 Ontology Gas Ontology Gas +23.11%
#6 UnifAI Network UnifAI Network +22.34%
#7 Glidr Glidr +22.29%
#8 Useless Coin Useless Coin +22.23%
#9 Falcon Finance Falcon Finance +17.76%
#10 Apertum Apertum +15.49%
Coin of the day
DogBull DogBull
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
TCM Biotech International Corp. TCM Biotech International Corp.

TCM Biotech International Corp.

4169
Clasificación en acciones #15795
TCM Biotech International Corp., a biotech company, engages in the research and... TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for liver diseases. The company offers medical devices, such as therapy for osteoarthritis, intra-articular implant of hyaluronic acid, automated blood cell separator, absorbable adhesion barrier material, prosthetic and orthotic accessory, and pellefeel mask pressure relief pad; and pharmaceuticals, including iron supplement, therapeutic agent for urinary system, expectorant/mucolytic agent, anticancer drug, antihypertensive drug, and antidiabetic. It also provides medical detection platform for breast cancer recurrent risk detection and postoperative detection platform for liver cancer, as well as philips non-invasive positive pressure ventilation and accessories. TCM Biotech International Corp. was founded in 1998 and is headquartered in New Taipei City, Taiwan.
Precio por acción
$4.96
Capitalización bursátil
$329.54M
Cambio (1 día)
2.63%
Cambio (1 año)
53.49%
País
TW
Comercio TCM Biotech International Corp. (4169)

Categoría

Healthcare
Ingresos de TCM Biotech International Corp. (4169)
Ingresos en Sep 2026 TTM: 0
Según los últimos informes financieros de TCM Biotech International Corp., los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de TCM Biotech International Corp. desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH